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Adolescent
Prescription Drug
Abuse
• Is this a problem? How do we find out?
• Which drugs are problematic and why?
• How can we address the problem?
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Is Prescription Drug Abuse
a Problem in Adolescents?
•
•
•

24% of teens report using prescription
drugs to get high
31% of teens believe there is “nothing
wrong” with using Rx drugs “once in a
while”
40% of teens believe Rx drugs are “much
safer” than illegal drugs
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Is Prescription Drug
Abuse a Problem in
Adolescents
• Almost 30% of teens believe Rx
analgesics are not addictive

• Every day 2500 teens use Rx drugs to
get high for the first time

• 60% of teens who have abused
painkillers did so before age 15

Is Prescription Drug
Abuse a Problem in
Adolescents
• Approximately 1/3 of parents believe

stimulants improve school performance
even if NOT diagnosed with ADHD

• Rx abuse killing more kids than any
other drugs of abuse

Which Drugs are
Problematic and Why?
• Opiates (U.S.: 4% world population;
80% world opiates)

• Stimulants
• Benzodiazepines
• Mixing- party bowls/”trail mix”, THC, etc
• Methamphetamine (prescriptionrelated)
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Opioid Analgesics
•

Hydrocodone

•
•
•

Most prescribed drug in
the United States
<5% of world population;
consume 99% of
hydrocodone

Common path:
Hydrocodone leads to
oxycodone leads to heroin

Drugs detected at
death
• Hydrocodone

Opioid Analgesics
•

Oxycodone

•
•

•

Short / Long-acting
Formulation
changes
Heroin cheaper

Drugs detected at
death
• Oxycodone

Methadone
•

•
•
•

Long-acting / Additive
Effects

4+ million rx’s for pain
in 2009
1999-2004: fourfold
increase in
methadone-related
overdose deaths
Heroin is cheaper

Drugs detected at
death
• Methadone

Drugs detected at
death
• Heroin

Stimulants
•
•
•

Amphetaminecontaining more
popular then
methylphenidate
Co-administer with
ethanol
Not a new issue, but
more available
(diversion)

Stimulants
•
•
•

1 in 8 teens (2.7
million) report using
stimulants at least
once
9% report using in last
year, 6% in last month
(both 50% increase
since 2008)
26% believe
stimulants can be
used as study aid

How Can We Address
the Problem?
• Educate parents: possibilities, secure
meds

• Educate young people
• Identify at risk, use/abuse, addiction
• Address supply
• Treatment
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Parents
•

Awareness:
educational
forums/materials,
counsel on visits

•
•

Only 14-16%
discussed Rx abuse
with kids
56% of abused
drugs came from
medicine cabinet of
family

Parents
•

Control Access

•
•
•

Secure home
medications
Medication disposal
Take-Backs

Young People
• Educate like voting: early and often
• Health maintenance, sports physicals,
acute visits, etc

• Factors to discuss: effects on
performance, COST, etc

Young People
• Identify at risk patients:
• Much of current research based on
treatment intake questionnaires

• Comorbid mental illness, family
history, social stressors

Programs for Young
People

• Lincoln County Youth Film Program
(2004-)

• High School film students produce
PSA spots

• http://vimeo.com/search?q=lincoln+co
unty+youth+film

• Wake Up! Program

http://www.wakeupnow.org
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Supply
•

Prescription Drug Monitoring Programs
(PDMP)

•
•
•

49/50 states have or developing
(Missouri?)
Vermont:
http://healthvermont.gov/adap/Vpms.as
px

Educate ourselves: pain management is
evolving
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What about Tamperresistant medications?
• OxyContin
• Resists crushing, dissolving, snorting,
injecting, smoking

• Mixed results
• Forums show theories for work
around

• Go to heroin

Methamphetamine
• Not a prescription drug?
• Labs in homes, bottles, etc (toxic
environment)

• Requires pseudoephedrine to make
most common form

Pseudoephedrine
2010: U.S. spent $600 million on drug, at
least 2x allergy sufferers’“need” (better
choices readily available)

• Oregon: 2006 Rx-only law (96% drop
in labs*). Mississippi followed.

• Mexico: 2007 outlawed

pseudoephedrine (switch to phenyl-2propanone, but harder to get/less
potent)

Adolescent Prescription
Drug Abuse
•
•
•

It is a potentially deadly problem (especially
opiates)
Multiple drugs / combinations are of concern
Address the issue at multiple levels

•
•
•
•

Parents

Adolescents
Medical professionals

Community
33

Thank You
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